Researchers have developed ViabiLens, an AI-powered software that can accurately count cells and predict their viability using only brightfield imaging, eliminating the need for traditional staining methods. This new approach combines a cell detection model with a convolutional neural network classifier and an interactive UMAP viewer. Tested on Chinese Hamster Ovary (CHO) cells, ViabiLens achieved a mean absolute error of 2.68% compared to fluorescence-based measurements, offering a less perturbing and more real-time method for cell viability assessment. AI
IMPACT Offers a less invasive and more accurate method for cell viability assessment in biopharmaceutical manufacturing and drug development.
RANK_REASON The cluster contains an academic paper detailing a new AI-based method for cell analysis. [lever_c_demoted from research: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →